Testing effectiveness (Phase 2)Study completedNCT01997905What this trial is testingStroke Feasibility StudyWho this might be right forAtrial FibrillationAFib AtriCure, Inc. 13
Not applicableUnknownNCT03987945What this trial is testingLeft Atrial Appendage Occlusion in Patients With Non-valvular Atrial Fibrillation From ShanghaiWho this might be right forAtrial FibrillationLeft Atrial Appendage Occlusion Shanghai 10th People's Hospital 150
Not applicableUnknownNCT04291287What this trial is testingTriple or Dual Antithrombotic Therapy After PCI (TRIDUAL-PCI) Coronary Intervention in Patients With Non-valvular Atrial Fibrillation. Real-world Italian Multicenter Registry (TRIDUAL-PCI)Who this might be right forAtrial FibrillationMyocardial InfarctionAnticoagulant-induced Bleeding+1 more Scientific Institute San Raffaele 1,500
Not applicableLooking for participantsNCT07042529What this trial is testingOptimized Expansion of the Implanted Transcatheter Aortic ValveWho this might be right forAortic Stenosis DiseaseValvular Heart Disease Ole De Backer 1,010
Not applicableUnknownNCT04550637What this trial is testingA Multi-center Study of Apixaban(APPROACH)Who this might be right forEvaluate the Safety and Efficacy of Apixaban Shanghai Zhongshan Hospital 200
Not applicableNot Yet RecruitingNCT07313228What this trial is testingPulsed Field Ablation for Non-valvular Atrial Fibrillation After Left Atrial Appendage OcclusionWho this might be right forAtrial FibrillationLeft Atrial Appendage OcclusionPulsed Field Ablation First Affiliated Hospital of Ningbo University 70
Not applicableLooking for participantsNCT07385599What this trial is testingFIM Study of the LAmbre™ II LAA Occluder in Non-Valvular AF PatientsWho this might be right forNon-valvular Atrial Fibrillation (NVAF) Lifetech Scientific (Shenzhen) Co., Ltd. 10
Large-scale testing (Phase 3)Study completedNCT00403767What this trial is testingAn Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial FibrillationWho this might be right forAtrial FibrillationStrokeEmbolism Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 14,269
Not applicableStudy completedNCT02559232What this trial is testingAn Observational Cross-sectional Study Evaluating the Use of Re-sources and the Sociodemographic and Clinical Characteristics of Patients Diagnosed With Non-valvular Atrial Fibrillation With a Risk of Stroke or Systemic Embolism on Anticoagulant Therapy and Treated in Primary Care CentersWho this might be right forStrokePrevention and ControlAtrial Fibrillation Bayer 247
Not applicableLooking for participantsNCT05654272What this trial is testingDevelopment of CIRC TechnologiesWho this might be right forCardiovascular DiseasesHeart FailureIschemic Heart Disease+7 more The Cleveland Clinic 1,000
Not applicableUnknownNCT03838341What this trial is testingStand-alone Totally Thoracoscopic Left Atrial Appendage Occlusion Using AtriClip® Device in Non-valvular Atrial Fibrillation.Who this might be right forStroke PreventionAtrial FibrillationSafety Issues Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland 100
Not applicableStudy completedNCT03803579What this trial is testingBaseline Concentration of Direct Oral Anticoagulant and Incidence of Adverse Event Measure And See (MAS)Who this might be right forAtrial FibrillationAnticoagulant-induced Bleeding Arianna Anticoagulazione Foundation 2,000
Post-approval studies (Phase 4)Enrolling By InvitationNCT06862726What this trial is testingApixaban Versus Rivaroxaban in Non Valvular Atrial FibrillationWho this might be right forNon Valvular Atrial Fibrillation Les Laboratoires des Médicaments Stériles 120
Not applicableStudy completedNCT01606995What this trial is testingXarelto for Prevention of Stroke in Patients With Atrial FibrillationWho this might be right forAtrial Fibrillation Bayer 6,784
Not applicableStudy completedNCT02941978What this trial is testingMotivational Interviewing to Support Oral AntiCoagulation Adherence in Patients With Non-valvular Atrial Fibrillation (MISOAC-AF)Who this might be right forPatient CompliancePatient Adherence AHEPA University Hospital 1,140
Not applicableStudy completedNCT03254134What this trial is testingComparative Effectiveness and Safety Between Warfarin and DabigatranWho this might be right forAtrial Fibrillation Boehringer Ingelheim 22,490
Not applicableUnknownNCT03133806What this trial is testingCanadian Left Atrial Appendage Closure StudyWho this might be right forLeft Atrial AppendageNon-Valvular Atrial Fibrillation Cardia Inc. 30
Not applicableNot Yet RecruitingNCT04956978What this trial is testingShared Decision Making to Address Racial Disparities in Oral Anticoagulation in NVAFWho this might be right forAtrial Fibrillation Duke University 40
Not applicableStudy completedNCT02661516What this trial is testingClinical and Economic Burden of Bleeding Events in Patients in the UK With Non-valvular Atrial Fibrillation Treated With Vitamin k AntagonistsWho this might be right forAtrial Fibrillation Bristol-Myers Squibb 16,513
Not applicableWithdrawnNCT03804125What this trial is testingAdverse Events and Suspected Adverse Drug Reactions in Patients Under Apixaban for Prevention of Stroke and Systemic Embolism With Non-Valvular Atrial Fibrillation and Venous Thromboembolic Events in Patients Who Have Undergone Elective Hip or Knee Replacement SurgeryWho this might be right forCerebral StrokeThrombosis, Deep VeinPulmonary Embolism Pfizer